drugset / Trial / NCT04082325
Study Investigating the Safety and Tolerability of Lu AF88434 in Healthy Young Men
RandomizedSequentialDouble-blindTreatment
Summary
This study evaluates the effect of Lu AF88434 on the body and what the body does to Lu AF88434 and the effect of food after swallowing single oral doses
Timeline
- Start
- 2019-07-23
- Primary completion
- 2020-09-24
- Completion
- 2020-09-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AF88434 | Unknown | 0.2 mg | Oral |
Indications
No indication recorded.